BIOAVAILABILITY AND PHARMACOKINETICS OF CYPROTERONE-ACETATE AFTER ORAL-ADMINISTRATION OF 2.0-MG CYPROTERONE-ACETATE IN COMBINATION WITH 50 MUG ETHINYLESTRADIOL TO 6 YOUNG-WOMEN

被引:22
作者
HUMPEL, M [1 ]
WENDT, H [1 ]
SCHULZE, PE [1 ]
DOGS, G [1 ]
WEISS, C [1 ]
SPECK, U [1 ]
机构
[1] SCHERING AG,RES LABS,BERLIN,FED REP GER
关键词
D O I
10.1016/0010-7824(77)90108-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:579 / 588
页数:10
相关论文
共 8 条
[1]  
BHARGAVA AP, IN PRESS
[2]  
GERHARDS E, 1973, ARZNEIMITTEL-FORSCH, V23, P1550
[3]  
HUMPEL M, IN PRESS
[4]  
Kolb K H, 1968, Int Z Klin Pharmakol Ther Toxikol, V1, P184
[5]  
NIEUWEBOER B, IN PRESS
[6]   PHARMACOKINETICS OF BETA-ADRENERGIC BLOCKER SOTALOL IN DOGS [J].
SCHNELLE, K ;
GARRETT, ER .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (03) :362-375
[7]   BIO-AVAILABILITY AND PHARMACOKINETICS OF CYPROTERONE ACETATE-C-14 AND ETHINYLOESTRADIOL-H-3 AFTER ORAL-ADMINISTRATION AS A COATED TABLET (SH B 209 AB) [J].
SPECK, U ;
WENDT, H ;
SCHULZE, PE ;
JENTSCH, D .
CONTRACEPTION, 1976, 14 (02) :151-163
[8]  
SPECK U, 1976, ARZNEIMITTEL-FORSCH, V26, P1717